Hadi Hezaveh

Hadi Hezaveh

Auto-generated profile, based on publicly available information

Hadi Hezaveh

Tissue Engineering and Microfluidics Laboratory, The Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Renewable and Sustainable Energy Reviews
Verified
Journal Article
Closed access
ATAmin Talebian-Kiakalaieh
Amin Talebian-Kiakalaieh
NANor Aishah Saidina Amin
Nor Aishah Saidina Amin
HHHadi Hezaveh
Hadi Hezaveh

1 March 2013 in Chemical Engineering Research and Design
Verified
Journal Article
Closed access
HHHadi Hezaveh
Hadi Hezaveh
IMIda Idayu Muhamad
Ida Idayu Muhamad

1 March 2013 in Journal of the Taiwan Institute of Chemical Engineers
Verified
Journal Article
Closed access
HHHadi Hezaveh
Hadi Hezaveh
IMIda Idayu Muhamad
Ida Idayu Muhamad

1 June 2012 in Carbohydrate Polymers
Verified
Journal Article
Closed access
HHHadi Hezaveh
Hadi Hezaveh
IMIda Idayu Muhamad
Ida Idayu Muhamad

18 January 2012 in Journal of Microencapsulation
Verified
Journal Article
Closed access
HHHadi Hezaveh
Hadi Hezaveh
IMIda Idayu Muhamad
Ida Idayu Muhamad
INIman Noshadi
Iman Noshadi
LFLim Shu Fen
Lim Shu Fen
NNNorzita Ngadi
Norzita Ngadi
We studied a model system of controlled drug release using beta-carotene and κ-carrageenan/NaCMC hydrogel as a drug and a device, respectively. Different concentrations of genipin were added to crosslink the beta-carotene loaded beads by using the dripping method. Results have shown that the cross-linked beads possess lower swelling ability in all pH conditions (pH 1.2 and 7.4), and swelling ratio decreases with increasing genipin concentration. Microstructure study shows that cross-linking has enhanced the stability and structure of the beads network. Determination of diffusion coefficient for the release of encapsulated beta-carotene indicates less diffusivity when beads are cross-linked. Swelling models using adaptive neuro fuzzy show that using genipin as a cross-linker in the kC/NaCMC hydrogels affects the transport mechanism. The model shows very good agreement with the experimental data that indicates that applying ANFIS modelling is an accurate, rapid and simple way to model in such a case for controlled release applications.

9 January 2015 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
SCSteffen Cosson
Steffen Cosson
EOEllen A. Otte
Ellen A. Otte
HHHadi Hezaveh
Hadi Hezaveh
JCJustin Cooper-White
Justin Cooper-White
The potential for the clinical application of stem cells in tissue regeneration is clearly significant. However, this potential has remained largely unrealized owing to the persistent challenges in reproducibly, with tight quality criteria, and expanding and controlling the fate of stem cells in vitro and in vivo. Tissue engineering approaches that rely on reformatting traditional Food and Drug Administration-approved biomedical polymers from fixation devices to porous scaffolds have been shown to lack the complexity required for in vitro stem cell culture models or translation to in vivo applications with high efficacy. This realization has spurred the development of advanced mimetic biomaterials and scaffolds to increasingly enhance our ability to control the cellular microenvironment and, consequently, stem cell fate. New insights into the biology of stem cells are expected to eventuate from these advances in material science, in particular, from synthetic hydrogels that display physicochemical properties reminiscent of the natural cell microenvironment and that can be engineered to display or encode essential biological cues. Merging these advanced biomaterials with high-throughput methods to systematically, and in an unbiased manner, probe the role of scaffold biophysical and biochemical elements on stem cell fate will permit the identification of novel key stem cell behavioral effectors, allow improved in vitro replication of requisite in vivo niche functions, and, ultimately, have a profound impact on our understanding of stem cell biology and unlock their clinical potential in tissue engineering and regenerative medicine.